logo

For the Inventor, By the Inventor

Holbæk, Denmark

Hans B Andreasen

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 73(Granted Patents)


Location History:

  • Viby Sjælland, DK (2001 - 2005)
  • Holbæk, DK (2014 - 2021)
  • Holbaek, DK (2020 - 2024)

Company Filing History:

goldMedal15 out of 25 
 
Pharmacosmos Holding A/s
 patents

Years Active: 2001-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12030962 - Stable iron oligosaccharide compound (2024-07-09),
2. 11851504 - Stable iron oligosaccharide compound (2023-12-26),
3. 11633489 - Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant (2023-04-25),
4. 11484025 - Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation (2022-11-01),
5. 11471483 - Iron carbohydrate complex for treatment of restless leg syndrome (RLS) (2022-10-18),
6. 11111261 - Iron complex compounds for therapeutic use (2021-09-07),
7. 11040064 - Iron carbohydrate complex for treatment of restless leg syndrome (RLS) (2021-06-22),
8. 11040059 - Treatment or prevention of anaemia in pregnant non-human mammals (2021-06-22),
9. 10960081 - Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant (2021-03-30),
10. 10865255 - Stable iron oligosaccharide compound (2020-12-15),
11. 10414831 - Stable iron oligosaccharide compound (2019-09-17),
12. 9439969 - Stable iron oligosaccharide compound (2016-09-13),
13. 8815301 - Stable iron oligosaccharide compound (2014-08-26),
14. 6977249 - Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of parenterally administrable pharmaceutical composition (2005-12-20),
15. 6291440 - Iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency (2001-09-18),

Title: The Innovations of Hans B Andreasen

Introduction

Hans B Andreasen is a notable inventor based in Holbæk, Denmark. He has made significant contributions to the field of iron oligosaccharide compounds, holding a total of 15 patents. His work focuses on improving the stability and efficacy of these compounds, which are essential in treating iron deficiency anemia.

Latest Patents

One of Hans B Andreasen's latest patents is for a stable iron oligosaccharide compound. This invention relates to an iron oligosaccharide compound with improved stability, comprising a hydrogenated oligosaccharide in stable association with ferric oxyhydroxide. The content of dimer saccharide in the hydrogenated oligosaccharide is 2.9% by weight or less, based on the total weight of the hydrogenated oligosaccharide. Additionally, the patent outlines a process for preparing this compound and its use in creating a composition for the treatment of iron deficiency anemia.

Career Highlights

Hans B Andreasen is currently associated with Pharmacosmos Holding A/S, a company that specializes in pharmaceutical products. His work at Pharmacosmos has allowed him to focus on innovative solutions for iron deficiency treatments, contributing to advancements in the medical field.

Collaborations

Throughout his career, Hans has collaborated with notable colleagues, including Tobias Sidelmann Christensen and Lars Lykke Thomsen. These collaborations have further enhanced the development of his inventions and the impact of his work in the industry.

Conclusion

Hans B Andreasen's contributions to the field of iron oligosaccharide compounds demonstrate his commitment to innovation and improving health outcomes. His patents and collaborations reflect a dedication to advancing medical treatments for iron deficiency anemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…